The Cleveland Clinic Foundation
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1921-01-01
- Employees
- 1K
- Market Cap
- -
GeneBank At the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease
Active, not recruiting
- Conditions
- Cardiovascular Diseases
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 9880
- Registration Number
- NCT00590200
Assessment of Left Ventricular Torsion by Echocardiography Study
Completed
- Conditions
- Hypertrophic Cardiomyopathy
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00589836
- Locations
- 🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
Safety Monitoring of Patients Having Pulmonary Vein Ablation
Completed
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 42
- Registration Number
- NCT00590668
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
Phase 2
Terminated
- Conditions
- LymphomaSecondary MyelofibrosisChronic Myeloproliferative DisordersLeukemiaPrecancerous/Nonmalignant ConditionMultiple Myeloma and Malignant Plasma Cell NeoplasmsMyelodysplastic Syndromes
- Interventions
- Procedure: peripheral blood lymphocyte therapyProcedure: allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantationRadiation: total-body irradiation (TBI)
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 13
- Registration Number
- NCT00589602
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
Not Applicable
Completed
- Conditions
- Internal Iliac AneurysmAbdominal Aortic AneurysmIliac Aneurysm
- Interventions
- Device: Endovascular Aneurysm Repair
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 401
- Registration Number
- NCT00583414
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
Not Applicable
Completed
- Conditions
- Thoracoabdominal AneurysmAbdominal Aortic Aneurysm
- Interventions
- Device: Endovascular Aneurysm Repair
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2020-05-08
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 1366
- Registration Number
- NCT00583050
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
The Use of CT to Identify Damaged Heart Muscle in Patients Undergoing Ventricular Tachycardia Ablation.
Terminated
- Conditions
- Ventricular Tachycardia
- First Posted Date
- 2007-12-31
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 4
- Registration Number
- NCT00583284
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
- First Posted Date
- 2007-12-28
- Last Posted Date
- 2013-02-11
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 14
- Registration Number
- NCT00582907
- Locations
- 🇺🇸
NYU Hospital for Joint Diseases, New York, New York, United States
🇺🇸Children's Hospital of Central California, Madera, California, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
Phase 4
Terminated
- Conditions
- Coronary Artery DiseaseInflammatory ResponseAtherosclerosis
- Interventions
- Dietary Supplement: eicosapentaenoic acid (EPA),
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2007-12-21
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 53
- Registration Number
- NCT00578578
- Locations
- 🇺🇸
Cleveland Clinic Willoughby Hills Family Health Center, Willoughby Hills, Ohio, United States
Clinical Implications of Peripheral Plaque Morphology
Completed
- Conditions
- Peripheral Artery Disease
- Interventions
- Other: Ivus (Intravascular Ultrasound) of Amputation SpecimensProcedure: IVUS (Intravascular Ultrasound)
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 143
- Registration Number
- NCT00578422
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath